94 related articles for article (PubMed ID: 8179718)
1. Gelatinase A and APP.
Miyazaki K; Funahashi K; Umeda M; Nakano A
Nature; 1994 Apr; 368(6473):695-6. PubMed ID: 8179718
[No Abstract] [Full Text] [Related]
2. Gelatinase A not alpha-secretase?
Walsh DM; Williams CH; Kennedy HE; Allsop D; Murphy G
Nature; 1994 Jan; 367(6458):27-8. PubMed ID: 7906388
[No Abstract] [Full Text] [Related]
3. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.
Miyazaki K; Hasegawa M; Funahashi K; Umeda M
Nature; 1993 Apr; 362(6423):839-41. PubMed ID: 8479521
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease.
LePage RN; Fosang AJ; Fuller SJ; Murphy G; Evin G; Beyreuther K; Masters CL; Small DH
FEBS Lett; 1995 Dec; 377(2):267-70. PubMed ID: 8543065
[TBL] [Abstract][Full Text] [Related]
5. The binding of gelatinases A and B to type I collagen yields both high and low affinity sites.
Allan JA; Docherty AJ; Murphy G
Ann N Y Acad Sci; 1994 Sep; 732():365-6. PubMed ID: 7978809
[No Abstract] [Full Text] [Related]
6. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice.
Itoh T; Ikeda T; Gomi H; Nakao S; Suzuki T; Itohara S
J Biol Chem; 1997 Sep; 272(36):22389-92. PubMed ID: 9278386
[TBL] [Abstract][Full Text] [Related]
7. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
[TBL] [Abstract][Full Text] [Related]
9. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK
Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge.
Warner JA; Julius P; Luttmann W; Kroegel C
Int Arch Allergy Immunol; 1997; 113(1-3):318-20. PubMed ID: 9130563
[No Abstract] [Full Text] [Related]
11. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion.
Stearns ME; Rhim J; Wang M
Clin Cancer Res; 1999 Jan; 5(1):189-96. PubMed ID: 9918218
[TBL] [Abstract][Full Text] [Related]
12. Effect of gonadotrophin on cell and matrix retention and expression of metalloproteinases and their inhibitor in cultured human granulosa cells modelling corpus luteum function.
Aston KE; Stamouli A; Thomas EJ; Vyas S; Iredale JP; Arthur MJ; Richardson MC
Mol Hum Reprod; 1996 Jan; 2(1):26-30. PubMed ID: 9238653
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
14. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
15. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Rifas L; Fausto A; Scott MJ; Avioli LV; Welgus HG
Endocrinology; 1994 Jan; 134(1):213-21. PubMed ID: 8275936
[TBL] [Abstract][Full Text] [Related]
16. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
17. The role of proteolysis in Alzheimer's disease.
Hooper NM; Trew AJ; Parkin ET; Turner AJ
Adv Exp Med Biol; 2000; 477():379-90. PubMed ID: 10849764
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma.
Charous SJ; Stricklin GP; Nanney LB; Netterville JL; Burkey BB
Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):271-8. PubMed ID: 9109715
[TBL] [Abstract][Full Text] [Related]
19. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
